READ MORE: Quebec-based pharmaceutical company donates 1 million doses of malaria-drug for COVID-19 patients across Canada The drug made international headlines this month when U.S. President Donald Trump touted it as a potential breakthrough treatment for COVID-19.
The drug has shown promise in some small, early trials.
